CoChat

IL4-driven microglia modulate stress resilience through BDNF-dependent neurogenesis

Open access

Published version of a preprint

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index; 5 of the 18 sources its claims cite were checked for support.

Abstract

Hippocampal microglia mediate stress resilience.

Overview

CoChat Summary

TL;DR

Hippocampal IL4 signaling distinguishes stress-resilient from stress-susceptible mice, and IL4 overexpression drives Arg1+ microglia that promote adult hippocampal neurogenesis via BDNF/TrkB. This microglial IL4–Arg1–BDNF axis reduces depressive-like behaviors after chronic mild stress.

Key findings

  • After 3-week CMS, high-susceptible (HS) mice had reduced hippocampal IL4 mRNA/protein and IL4–STAT6 signaling, whereas low-susceptible (LS) mice had elevated IL4; hippocampal IL4 concentration positively correlated with sucrose preference and negatively with TST immobility.
  • Hippocampal AAV-IL4 increased Arg1+ microglia and reduced iNOS in CMS-exposed mice. RNA-seq found 65 DEGs in AAV+CMS vs AAV mice (31 up, 34 down) and 760 DEGs in AAV-IL4+CMS vs AAV+CMS mice (597 up, 163 down), with Arg1 among the most up-regulated.
  • IL4-driven Arg1+ microglia reversed CMS-induced deficits in NSPC proliferation, differentiation, survival, and maturation; microglial IL4Rα knockdown reduced Arg1+ microglia and blocked IL4-rescued neurogenesis.
  • The proneurogenic and antidepressant-like effects required BDNF/TrkB: BDNF was up-regulated in AAV-IL4+CMS mice, and K252a or anti-BDNF antibody blocked the increase in DCX+ and BrdU+-DCX+ cells; K252a or TMZ also abolished IL4’s behavioral protection.

Methods

  • Male C57BL/6J and CX3CR1Cre/ERT2 mice underwent CMS (3 weeks for HS/LS screening, 4 weeks for depression model, 2 weeks for subliminal CMS) and were assessed by sucrose preference, FST, and TST.
  • Hippocampal IL4 was overexpressed with rAAV2/9-IL4; microglial IL4Rα was knocked down with lentiviral LoxP-shIL4Rα in CX3CR1Cre/ERT2 mice. BDNF/TrkB was blocked with K252a or anti-BDNF antibody; neurogenesis was suppressed with TMZ.
  • Outcomes included RNA-seq, qPCR, ELISA, Western blotting, RNAscope, immunohistochemistry, flow cytometry, BrdU labeling, and NSPC cultures with microglia-conditioned medium.

Limitations

  • Stated: AAV vector–mediated microglial reprogramming may cause local tissue damage and microglial activation; isolated microglia may not maintain the same functions as in vivo microglia; further studies with microglia-specific BDNF depletion are needed; human adult hippocampal neurogenesis remains controversial.
  • Evident: experiments used male mice only, so sex differences are not addressed; several key conclusions rely on correlational analyses (e.g., IL4/Arg1/BDNF with behavior) alongside causal manipulations.
  • Evident: the paper does not directly deplete BDNF specifically from microglia, so the cell source of BDNF is supported by expression/localization and pharmacological blockade rather than microglia-specific genetic loss.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1126/sciadv.abb9888

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Hippocampal IL4 levels and Arg1+ microglia are involved in resistance of mice to stress. (A) Behavioral screening of LS and HS subpopulations of mice exposed to 3-week CMS. (B) Quantitative PCR to examine mRNA expression of cytokines, chemokines, growth factors, and trophic factors in the hippocampus and prefrontal cortex of HS and LS mice. Data are standardized to control group (n = 4 to 6, each sample in triplicate). (C) Enzyme-linked immunosorbent assay to assay the protein level of IL4 in prefrontal cortex, cerebellum, hippocampus, amygdala, and olfactory bulb of control, HS, and LS mice. Each circle represents one mouse (n = 6, each sample in triplicate). (D) Western blotting shows the levels of IL4, IL4 receptor α chain (IL4Rα), STAT6, and pSTAT6 in the hippocampus of control, HS, and LS mice. IL4 and IL4Rα are normalized to β-actin, and the pSTAT6 is normalized to STAT6. (n = 4 to 6, each sample in triplicate). (E) Correlation between sucrose preference or immobility duration in TST, hippocampal Arg1 levels, and hippocampal IL4 levels in CMS-exposed mice. Each circle represents one mouse (n = 6). (F) Morphological characters of hippocampal microglia in control, HS, and LS mice. Scale bars, 50 μm (top) and 10 μm (bottom). The histogram represents the quantification of number and branch length of Iba1+ cells in hippocampus. Each dot in the bar graph represents the average of all micrograph (five to six micrographs for each mouse) in each mouse (n = 5). (G) Immunofluorescence micrographs and quantification of Arg1+ microglia in hippocampus of control, LS, and HS mice (n = 5). Scale bars, 50 μm. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, one-way ANOVA with Tukey test (B, C, D, F, and G). DAPI, 4′,6-diamidino-2-phenylindole.
Fig. 1 Hippocampal IL4 levels and Arg1+ microglia are involved in resistance of mice to stress. (A) Behavioral screening of LS and HS subpopulations of mice exposed to 3-week CMS. (B) Quantitative PCR to examine mRNA expression of cytokines, chemokines, growth factors, and trophic factors in the hippocampus and prefrontal cortex of HS and LS mice. Data are standardized to control group (n = 4 to 6, each sample in triplicate). (C) Enzyme-linked immunosorbent assay to assay the protein level of IL4 in prefrontal cortex, cerebellum, hippocampus, amygdala, and olfactory bulb of control, HS, and LS mice. Each circle represents one mouse (n = 6, each sample in triplicate). (D) Western blotting shows the levels of IL4, IL4 receptor α chain (IL4Rα), STAT6, and pSTAT6 in the hippocampus of control, HS, and LS mice. IL4 and IL4Rα are normalized to β-actin, and the pSTAT6 is normalized to STAT6. (n = 4 to 6, each sample in triplicate). (E) Correlation between sucrose preference or immobility duration in TST, hippocampal Arg1 levels, and hippocampal IL4 levels in CMS-exposed mice. Each circle represents one mouse (n = 6). (F) Morphological characters of hippocampal microglia in control, HS, and LS mice. Scale bars, 50 μm (top) and 10 μm (bottom). The histogram represents the quantification of number and branch length of Iba1+ cells in hippocampus. Each dot in the bar graph represents the average of all micrograph (five to six micrographs for each mouse) in each mouse (n = 5). (G) Immunofluorescence micrographs and quantification of Arg1+ microglia in hippocampus of control, LS, and HS mice (n = 5). Scale bars, 50 μm. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, one-way ANOVA with Tukey test (B, C, D, F, and G). DAPI, 4′,6-diamidino-2-phenylindole.CC BY-NC · PubMed Central
Fig. 2 Overexpression of IL4 in the hippocampus enhanced Arg1+ microglia phenotypes and mediated neuroinflammatory responses to CMS paradigm. (A) Experimental timeline of IL4 overexpression in the hippocampus and CMS protocol. (B) Volcano maps indicate differentially expressed genes (DEGs) in the brains of CMS-exposed and/or AAV-IL4–treated mice. (C) Quantitative PCR examination of the expression of several DEGs in the hippocampus of mice (n = 4 to 6). (D) Western blotting shows the levels of IL4, Arg1, and iNOS in the hippocampus of CMS-exposed and/or AAV-IL4–treated mice (n = 5 to 6). (E) Morphological characters of Arg1+ microglia in hippocampus. Scale bar, 100 μm. The histogram represents the quantification of number and branch length of Arg1+-Iba1+ cells in hippocampus. Each dot in the bar graph represents the average of five to six micrographs in each mouse (n = 6). (F) Flow cytometry of single-cell suspension of the whole hippocampus for microglia (CD45int-CD11b+ cells), activated microglia (CD86+ cells), and anti-inflammatory microglia (CD86+-CD206+ cells). The histogram represents the quantification of CD45int-CD11b+ cells, CD86+ cells, and CD86+-CD206+ cells (n = 5 to 6). Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005 versus AAV + Ctrl group, #P < 0.05, ##P < 0.01, ###P < 0.005 versus AAV + CMS group, two-way ANOVA with Tukey test (C); *P < 0.05, **P < 0.01, ***P < 0.005, two-way ANOVA with Tukey test (D, E, and F). FITC A, fluorescein isothiocyanate area (FITC-A).
Fig. 2 Overexpression of IL4 in the hippocampus enhanced Arg1+ microglia phenotypes and mediated neuroinflammatory responses to CMS paradigm. (A) Experimental timeline of IL4 overexpression in the hippocampus and CMS protocol. (B) Volcano maps indicate differentially expressed genes (DEGs) in the brains of CMS-exposed and/or AAV-IL4–treated mice. (C) Quantitative PCR examination of the expression of several DEGs in the hippocampus of mice (n = 4 to 6). (D) Western blotting shows the levels of IL4, Arg1, and iNOS in the hippocampus of CMS-exposed and/or AAV-IL4–treated mice (n = 5 to 6). (E) Morphological characters of Arg1+ microglia in hippocampus. Scale bar, 100 μm. The histogram represents the quantification of number and branch length of Arg1+-Iba1+ cells in hippocampus. Each dot in the bar graph represents the average of five to six micrographs in each mouse (n = 6). (F) Flow cytometry of single-cell suspension of the whole hippocampus for microglia (CD45int-CD11b+ cells), activated microglia (CD86+ cells), and anti-inflammatory microglia (CD86+-CD206+ cells). The histogram represents the quantification of CD45int-CD11b+ cells, CD86+ cells, and CD86+-CD206+ cells (n = 5 to 6). Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005 versus AAV + Ctrl group, #P < 0.05, ##P < 0.01, ###P < 0.005 versus AAV + CMS group, two-way ANOVA with Tukey test (C); *P < 0.05, **P < 0.01, ***P < 0.005, two-way ANOVA with Tukey test (D, E, and F). FITC A, fluorescein isothiocyanate area (FITC-A).CC BY-NC · PubMed Central
Fig. 3 Knockdown of microglial IL4Rα decreased the Arg1+ microglia phenotype in the hippocampus and increased the vulnerability of mice to stress. (A) Western blotting shows the levels of IL4Rα, Arg1, STAT6, and pSTAT6 in the hippocampal microglia of LS and HS mice (n = 3). (B) Western blotting shows the levels of IL4Rα, Arg1, STAT6, and pSTAT6 in the hippocampal microglia of LoxP-shIL4Rα–injected CX3CR1Cre/ERT2 mice after tamoxifen treatment (n = 6). (C) Effects of knockdown microglial IL4Rα combined with sCMS exposure on depressive-like behaviors, percentage of Arg1+ microglia, and cytokine expression of CX3CR1Cre/ERT2 mice (n = 8 for behavioral analysis, n = 6 for quantification of Arg1+ microglia, n = 4 to 6 for analysis of cytokine expression). Scale bar, 50 μm. (D) Effects of microglial IL4Rα knockdown in the hippocampus on the ratio of Arg1+ microglia, number, and length of branches of Iba1+ cells (n = 5). Scale bar, 50 μm. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, one-way ANOVA with Tukey test (A), two-tailed t test (B), two-way ANOVA with Bonferroni test for behavioral analysis (C), and two-way ANOVA with Tukey test for quantification of Arg1+ microglia (C), #P < 0.05, ##P < 0.01, ###P < 0.005 versus shRNA/M + sCMS group, two-way ANOVA with Tukey test for analysis of cytokine expression (C).
Fig. 3 Knockdown of microglial IL4Rα decreased the Arg1+ microglia phenotype in the hippocampus and increased the vulnerability of mice to stress. (A) Western blotting shows the levels of IL4Rα, Arg1, STAT6, and pSTAT6 in the hippocampal microglia of LS and HS mice (n = 3). (B) Western blotting shows the levels of IL4Rα, Arg1, STAT6, and pSTAT6 in the hippocampal microglia of LoxP-shIL4Rα–injected CX3CR1Cre/ERT2 mice after tamoxifen treatment (n = 6). (C) Effects of knockdown microglial IL4Rα combined with sCMS exposure on depressive-like behaviors, percentage of Arg1+ microglia, and cytokine expression of CX3CR1Cre/ERT2 mice (n = 8 for behavioral analysis, n = 6 for quantification of Arg1+ microglia, n = 4 to 6 for analysis of cytokine expression). Scale bar, 50 μm. (D) Effects of microglial IL4Rα knockdown in the hippocampus on the ratio of Arg1+ microglia, number, and length of branches of Iba1+ cells (n = 5). Scale bar, 50 μm. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, one-way ANOVA with Tukey test (A), two-tailed t test (B), two-way ANOVA with Bonferroni test for behavioral analysis (C), and two-way ANOVA with Tukey test for quantification of Arg1+ microglia (C), #P < 0.05, ##P < 0.01, ###P < 0.005 versus shRNA/M + sCMS group, two-way ANOVA with Tukey test for analysis of cytokine expression (C).CC BY-NC · PubMed Central
Fig. 4 IL4-driven Arg1+ microglia enhanced hippocampal neurogenesis in CMS-exposed mice. (A) Immunofluorescence micrographs and quantification show the hippocampal neurogenesis of LS and HS mice (n = 5). (B) GO enrichment analysis for DEGs in the hippocampus of CMS-exposed mice. ER, endoplasmic reticulum; FDR, false discovery rate. (C) Effects of IL4 overexpression and/or microglial IL4Rα down-regulation on NSPC proliferation and differentiation in the hippocampus of CX3CR1Cre/ERT2 mice. Representative fluorescence micrographs showing DCX expression and BrdU incorporation in the subgranular zone (SGZ). Scale bar, 100 μm. Quantification of total number of BrdU+ cells, total number of DCX+-BrdU+ cells, and percentage of DCX+-BrdU+ cells out of all BrdU+ cells in the neurogenic zones (n = 5). (D) Effects of IL4 overexpression and/or microglial IL4Rα down-regulation in the hippocampus (before IL4 overexpression) on NSPC survival and maturation. Representative fluorescence micrographs illustrating NeuN expression and BrdU incorporation in the SGZ. Scale bar, 100 μm. Quantification of total number of BrdU+ cells, BrdU+-NeuN+ cells, and DCX+-NeuN+ cells in DG (n = 5). (E) Effects of conditioned medium from microglia isolated from hippocampus on NSPC proliferation. Proliferation was monitored by quantifying the percentage of BrdU+ cells (n = 6). Scale bar, 50 μm. Representative micrographs of NSPCs cultured for 7 days in conditioned culture medium from microglia isolated from hippocampus. Cells were immunolabeled with glial fibrillary acidic protein (GFAP) to identify astrocytes and MAP2 to identify neurons. Percentages of GFAP+ cells and MAP2+ cells are quantified (n = 6). Scale bar, 30 μm. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, one-way ANOVA with Tukey test (A) and two-way ANOVA with Tukey test (C, D, and E).
Fig. 4 IL4-driven Arg1+ microglia enhanced hippocampal neurogenesis in CMS-exposed mice. (A) Immunofluorescence micrographs and quantification show the hippocampal neurogenesis of LS and HS mice (n = 5). (B) GO enrichment analysis for DEGs in the hippocampus of CMS-exposed mice. ER, endoplasmic reticulum; FDR, false discovery rate. (C) Effects of IL4 overexpression and/or microglial IL4Rα down-regulation on NSPC proliferation and differentiation in the hippocampus of CX3CR1Cre/ERT2 mice. Representative fluorescence micrographs showing DCX expression and BrdU incorporation in the subgranular zone (SGZ). Scale bar, 100 μm. Quantification of total number of BrdU+ cells, total number of DCX+-BrdU+ cells, and percentage of DCX+-BrdU+ cells out of all BrdU+ cells in the neurogenic zones (n = 5). (D) Effects of IL4 overexpression and/or microglial IL4Rα down-regulation in the hippocampus (before IL4 overexpression) on NSPC survival and maturation. Representative fluorescence micrographs illustrating NeuN expression and BrdU incorporation in the SGZ. Scale bar, 100 μm. Quantification of total number of BrdU+ cells, BrdU+-NeuN+ cells, and DCX+-NeuN+ cells in DG (n = 5). (E) Effects of conditioned medium from microglia isolated from hippocampus on NSPC proliferation. Proliferation was monitored by quantifying the percentage of BrdU+ cells (n = 6). Scale bar, 50 μm. Representative micrographs of NSPCs cultured for 7 days in conditioned culture medium from microglia isolated from hippocampus. Cells were immunolabeled with glial fibrillary acidic protein (GFAP) to identify astrocytes and MAP2 to identify neurons. Percentages of GFAP+ cells and MAP2+ cells are quantified (n = 6). Scale bar, 30 μm. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, one-way ANOVA with Tukey test (A) and two-way ANOVA with Tukey test (C, D, and E).CC BY-NC · PubMed Central
Fig. 5 IL4-driven microglia modulate adult hippocampal neurogenesis in a BDNF-dependent manner. (A) Western blotting shows the levels of BDNF and TrkB in the hippocampus of LS and HS mice. BDNF and TrkB are normalized to β-actin (n = 3). (B) Western blotting shows the levels of BDNF and TrkB in the hippocampus of CMS and/or AAV-IL4–treated mice. BDNF and TrkB are normalized to β-actin (n = 4). (C) BDNF was detected in hippocampal microglia (Iba1+ cells) using Bdnf-RNAscope. (D) The mRNA expression of BDNF was observed in hippocampal microglia of AAV-IL4–treated mice (n = 4). (E) Double immunohistochemical staining of BDNF and Arg1 in the hippocampus of AAV-IL4 mice. Scale bar, 20 μm. (F) Effects of CMS, knockdown of microglial IL4Rα, and overexpression of IL4 on BDNF protein levels in the hippocampus (n = 5). (G) Effects of k252a treatment to block the BDNF/TrkB pathway on hippocampal neurogenesis in AAV-IL4 mice under CMS exposure. Representative fluorescence micrographs showing DCX expression and BrdU incorporation in the SGZ. Scale bar, 100 μm. Quantification of the number of DCX+ cells and total number of DCX+-BrdU+ cells in the neurogenic zones (n = 5). DMSO, dimethyl sulfoxide. (H) The expression and secretion of BDNF in primary microglia after IL4 treatment in vitro (n = 6). (I) Effects of anti-BDNF antibody or K252a on NSPC proliferation (BrdU+ cells) in the presence of the conditioned culture medium from IL4-treated microglia (n = 5). Scale bar, 20 μm. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, one-way ANOVA with Tukey test (A, G, and I), two-way ANOVA with Tukey test (B, D, and F), and two-tailed t test (H).
Fig. 5 IL4-driven microglia modulate adult hippocampal neurogenesis in a BDNF-dependent manner. (A) Western blotting shows the levels of BDNF and TrkB in the hippocampus of LS and HS mice. BDNF and TrkB are normalized to β-actin (n = 3). (B) Western blotting shows the levels of BDNF and TrkB in the hippocampus of CMS and/or AAV-IL4–treated mice. BDNF and TrkB are normalized to β-actin (n = 4). (C) BDNF was detected in hippocampal microglia (Iba1+ cells) using Bdnf-RNAscope. (D) The mRNA expression of BDNF was observed in hippocampal microglia of AAV-IL4–treated mice (n = 4). (E) Double immunohistochemical staining of BDNF and Arg1 in the hippocampus of AAV-IL4 mice. Scale bar, 20 μm. (F) Effects of CMS, knockdown of microglial IL4Rα, and overexpression of IL4 on BDNF protein levels in the hippocampus (n = 5). (G) Effects of k252a treatment to block the BDNF/TrkB pathway on hippocampal neurogenesis in AAV-IL4 mice under CMS exposure. Representative fluorescence micrographs showing DCX expression and BrdU incorporation in the SGZ. Scale bar, 100 μm. Quantification of the number of DCX+ cells and total number of DCX+-BrdU+ cells in the neurogenic zones (n = 5). DMSO, dimethyl sulfoxide. (H) The expression and secretion of BDNF in primary microglia after IL4 treatment in vitro (n = 6). (I) Effects of anti-BDNF antibody or K252a on NSPC proliferation (BrdU+ cells) in the presence of the conditioned culture medium from IL4-treated microglia (n = 5). Scale bar, 20 μm. Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, one-way ANOVA with Tukey test (A, G, and I), two-way ANOVA with Tukey test (B, D, and F), and two-tailed t test (H).CC BY-NC · PubMed Central
Fig. 6 IL4-driven Arg1+ microglia protected mice from stress-induced depressive-like behaviors. (A) Effects of overexpression of IL4 in the hippocampus on stress-induced depressive-like behaviors. Mice were injected stereotactically with AAV-IL4 or AAV, allowed to recover for 2 weeks, and then subjected to a CMS protocol consisting of exposure to three random stressors daily for 4 weeks. The mice were assessed by SPT and FST (n = 8). (B) Correlations between sucrose preference and percentage of Arg1+ microglia in hippocampus, immobility time in FST and percentage of Arg1+ microglia in hippocampus, sucrose preference and concentration of BDNF in hippocampus, immobility time in FST and concentration of BDNF in hippocampus, sucrose preference and number of BrdU+-DCX+ cells in DG, and immobility time in FST and number of BrdU+-DCX+ cells in DG. Each circle represents one mouse (n = 6). (C) Effects of microglial IL4Rα down-regulation (before IL4 overexpression) on stress-induced depressive-like behaviors, as assessed by SPT and FST (n = 8 to 10). (D) Assessment of stress-induced depressive-like behaviors in WT mice when treated with K252a or TMZ with sCMS exposure (n = 8). (E) Assessment of stress-induced depressive-like behaviors in AAV-IL4 mice when treated with k252a or TMZ (n = 8 to 10). Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, two-way ANOVA with Bonferroni test (A and C) and one-way ANOVA with Bonferroni test (D and E).
Fig. 6 IL4-driven Arg1+ microglia protected mice from stress-induced depressive-like behaviors. (A) Effects of overexpression of IL4 in the hippocampus on stress-induced depressive-like behaviors. Mice were injected stereotactically with AAV-IL4 or AAV, allowed to recover for 2 weeks, and then subjected to a CMS protocol consisting of exposure to three random stressors daily for 4 weeks. The mice were assessed by SPT and FST (n = 8). (B) Correlations between sucrose preference and percentage of Arg1+ microglia in hippocampus, immobility time in FST and percentage of Arg1+ microglia in hippocampus, sucrose preference and concentration of BDNF in hippocampus, immobility time in FST and concentration of BDNF in hippocampus, sucrose preference and number of BrdU+-DCX+ cells in DG, and immobility time in FST and number of BrdU+-DCX+ cells in DG. Each circle represents one mouse (n = 6). (C) Effects of microglial IL4Rα down-regulation (before IL4 overexpression) on stress-induced depressive-like behaviors, as assessed by SPT and FST (n = 8 to 10). (D) Assessment of stress-induced depressive-like behaviors in WT mice when treated with K252a or TMZ with sCMS exposure (n = 8). (E) Assessment of stress-induced depressive-like behaviors in AAV-IL4 mice when treated with k252a or TMZ (n = 8 to 10). Data are presented as means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.005, two-way ANOVA with Bonferroni test (A and C) and one-way ANOVA with Bonferroni test (D and E).CC BY-NC · PubMed Central

Verification

Claims the paper makes

4 Valid · 0 Not valid · 8 Not checked · 111 Own results and interpretations

83 more claims

Create a free account to see all 123 claims and to verify the 13 references still open.

See all claims — free account
  • Probably not a substantial claim. 11
  • It may state two separate claims as one. 24
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 60 references

Cited by

Items 101–200 of 290

Metadata

Authors
Zhang, J., Rong, P., Zhang, L., He, H., Zhou, T., Fan, Y., Mo, L., Zhao, Q., Han, Y., Li, S., Wang, Y., Yan, W., Chen, H., & You, Z.
Affiliations
  • University of Electronic Science and Technology of China (CN)
  • China Academy of Chinese Medical Sciences (CN)
  • School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, China.
Corresponding author
  • Chen, Huafu
  • You, Zili
Venue
Science Advances
Published
2021-03-19
Volume
7
Issue
12
ISSN
2375-2548 (ISSN-L)
OpenAlex
W3137474792
Cited by
287
References
60
Citations by year
2026: 32 · 2025: 58 · 2024: 55 · 2023: 60 · 2022: 53 · 2021: 27
FWCI
17.70
Type
journal article
Language
en
Open access
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81571174, 81701308, U1808204)
  • Sichuan Science and Technology Program (2020YJ0225)
  • the 863 project (2015AA020505)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
microglia, IL-4, brain-derived neurotrophic factor, hippocampal neurogenesis, stress resilience, chronic stress, depression, microglial phenotype, mood disorders, neuroinflammation
MeSH terms
Hippocampus, Interleukin-4, Microglia, Brain-Derived Neurotrophic Factor, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.